Prentice Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-39
Closed -$1K 116
2021
Q3
$1K Hold
39
﹤0.01% 309
2021
Q2
$1K Hold
39
﹤0.01% 307
2021
Q1
$2K Buy
+39
New +$1.83K ﹤0.01% 293

Other funds holding AVNS

Prentice Wealth Management's AVNS Position: Q4 2021 in Review

Prentice Wealth Management sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 39 shares — an estimated $1K sold.

Prentice Wealth Management first reported a position in AVNS in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q1 2021. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

  • Prentice Wealth Management reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
  • Prentice Wealth Management sold 39 Avanos Medical shares in Q4 2021, an estimated $1K.
  • Prentice Wealth Management first reported a position in Avanos Medical in Q1 2021 and held it in 3 quarters.
  • Prentice Wealth Management's Avanos Medical position peaked at $2K in Q1 2021.
  • 297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Prentice Wealth Management's 13F filing for Q4 2021, filed 31 Oct 2022.